课题基金 / 基金详情

Analysis of the mechanism for suppression of childhood leukemia via ARF-p53 pathway

Analysis of the mechanism for suppression of childhood leukemia via ARF-p53 pathway
ARF-p53通路抑制儿童白血病的机制分析
批准号:
12670736
负责人:
KAMIJO Takehiko
金额:
$2.18万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

KAMIJO Takehiko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ARF, a tumor suppressor gene product, is seemed to protect cells from leukemic transformation via p53-dependent pathway. In this study, we performed the analysis of lymphocyte surface markers on ARF-null lymphocytes and examined hematopoietic cell colony formation from bone marrow cells cultured in the presence of several combinations of the cytokines. However, ARF-null cells did not possess specific surface makers and growth advantage compared to wild-type cells. ARF sensitizes cells to apoptosis in the presence of appropriate collateral signals. Therefore, we analyzed the mechanism of ARF-dependent apoptosis to study the role of ARF on tumor suppression. We demonstrated that ARF induces mitochondria-dependent apoptosis in p53 wild-type cells. We also found that ARF evokes cytochrome c release from mitochondria, decreases mitochondrial membrane potential and activates pro-caspase-9 to induce apoptosis. This pro-apoptotic cellular modulation appeared to be brought about by upregulation of the ratio of two sets of pro-apoptotic/anti-apoptotic initochondrial proteins, Bax/Bcl-2 and Bim/Bcl-2. Whereas downregulation of Bcl-2 by ARF was via a p53-dependent pathway, Bax and Bim upregulation was induced by serum starvation.
期刊论文(20)
专著(0)
科研奖励(0)
会议论文
Hagimoto R: "A possible role for maternal HLA antibodyin a case of alloimmune neonatal neutropenia"Transfusion. 41. 615-620 (2001)
Hagimoto R:“母体 HLA 抗体在同种免疫新生儿中性粒细胞减少症中的可能作用”输血。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
上條岳彦: "p53とARFによる癌抑制能"血液・腫瘍科. 42. 537-544 (2001)
Takehiko Kamijo:“p53 和 ARF 的癌症抑制能力”血液学和肿瘤学系 42. 537-544 (2001)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
上條岳彦: "p53とARFによる癌抑制能"血液・腫瘍科. 42巻6号. 537-544 (2001)
Takehiko Kamijo:“p53 和 ARF 的癌症抑制能力”,血液学和肿瘤学系,第 42 卷,第 6 期。537-544(2001 年)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
17
    Development of cancer stem cell-targeted therapy by study of tumor sphere formation mechanism using comprehensive and genetic approach
    Screening of polycomb Bmi1 targets for development of Cancer Stem Cell-targeted therapy for neuroblastoma
    • 批准号:
      21591377
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2009
    • 负责人:
      KAMIJO Takehiko
    • 依托单位:
    Investigation of new molecular target of neuroblastoma therapy: The role of p53 pathway in neuroblastoma cell death
    Investigation of a new molecular target-based treatment of caneer-drug resistant pediatric solid tumors
    • 批准号:
      15591098
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2003
    • 负责人:
      KAMIJO Takehiko
    • 依托单位:
    国内基金
    海外基金
    基于影像组学与代谢组学特征图谱的机器学习模型在P53突变型子宫内膜癌中的临床应用研究
    • 批准号:
      2026JJ82384
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      颜志鹏
    • 依托单位:
    Circ_0001313/miR-338-3p经P53调控铁死亡降低结直肠癌放化疗敏感性的机制
    APR-246靶向突变p53通路逆转DLBCL耐药的分子功能及机制研究
    • 批准号:
      JCZRQNB202600696
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    黄芩素通过p53信号通路逆转胃黏膜肠上皮化生的机制研究